glp-1 company MEDVi is showing what a new kind of can look like A telehealth platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B GLP-1 US |
Description
I can play with my grandchildren again, and Im even considering getting back on the tennis court

After their success in the obesity field, GLP-1 agonists are gaining interest in addiction treatment

Promotes healthy digestion and regularity*

It does not titrate up

Haverly is an expert LASIK and Cataract surgeon

Our licensed providers create custom treatment plans based on your unique goals and health history, with ongoing telehealth support every step of the way
